Are you saying shareholders have lost faith in the company? Whatever the mindset, the way I see it is that we have constant revenue streams from epichem and potentially life saving new uses for already approved drugs under Pitney Pharmaceuticals, and as you say, working with highly reputable organisations - this all encompasses are very real opportunity and I feel we've all been well informed regarding the canine trial. We will need to recruit more for the human trials but the main thing is that we are progressing.
Ann: Appendix 4C Quarterly & Company Update, page-32
-
- There are more pages in this discussion • 24 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
19.5¢ |
Change
-0.010(4.88%) |
Mkt cap ! $94.85M | |||
| Open | High | Low | Value | Volume |
| 20.5¢ | 21.0¢ | 19.0¢ | $186.0K | 934.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 115487 | 19.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.0¢ | 54290 | 2 |
View Market Depth
| Last trade - 13.32pm 30/09/2024 (20 minute delay) ? |
| PAA (ASX) Chart |